Personalis, Inc.
Offers advanced cancer genomics and data analysis for personalized therapies.
PSNL | US
Overview
Corporate Details
- ISIN(s):
- US71535D1063
- LEI:
- Country:
- United States of America
- Address:
- 6600 DUMBARTON CIRCLE, 94555 FREMONT
- Website:
- https://www.personalis.com/
- Industry:
- Other human health activities
Description
Personalis, Inc. is a company specializing in advanced cancer genomics that provides sequencing and data analysis solutions to transform the active management of cancer. The company's core technology is the NeXT Platform, which supports a suite of advanced genomic tests. Key offerings include NeXT Personal®, an ultra-sensitive, personalized liquid biopsy test for detecting molecular residual disease (MRD) and cancer recurrence earlier than standard imaging. The company also offers NeXT Dx™, a comprehensive tumor profiling service that analyzes the exome to help guide targeted therapy decisions. For its biopharmaceutical partners, Personalis provides the ImmunoID NeXT® platform, a biomarker analysis tool that supports the development of personalized cancer therapies and vaccines. By combining deep genomic sequencing with advanced analytics, Personalis aims to provide critical insights for clinicians and researchers to enable personalized treatment strategies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Personalis, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Personalis, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Personalis, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||